Comparative effectiveness and survival of infliximab, adalimumab, and etanercept for rheumatoid arthritis patients in the Hellenic Registry of Biologics: Low rates of …
…, D Zisopoulos, FN Skopouli, A Iliopoulos… - Seminars in arthritis and …, 2014 - Elsevier
… Skopouli MD g , Alexios Iliopoulos MD h , George K. Bertsias MD a , Pierre Geborek MD i
, Alexandros A. Drosos MD, FACR b , Dimitrios T. …
, Alexandros A. Drosos MD, FACR b , Dimitrios T. …
Successful treatment of refractory adult-onset Still's disease with infliximab. A prospective, non-comparative series of four patients
A Kokkinos, A Iliopoulos, P Greka, A Efthymiou… - Clinical …, 2004 - Springer
In this prospective, non-comparative case series, four patients with severe and highly active
adult-onset Still’s disease (AOSD), refractory to high doses of corticosteroids (which had …
adult-onset Still’s disease (AOSD), refractory to high doses of corticosteroids (which had …
Comparative analysis and predictors of 10-year tumor necrosis factor inhibitors drug survival in patients with spondyloarthritis: first-year response predicts longterm …
…, L Settas, D Zisopoulos, A Iliopoulos… - The Journal of …, 2018 - jrheum.org
Objective. To evaluate the 10-year drug survival of the first tumor necrosis factor inhibitor (TNFi)
administered to patients with spondyloarthritis (SpA) overall and comparatively between …
administered to patients with spondyloarthritis (SpA) overall and comparatively between …
Tuberculosis and targeted synthetic or biologic DMARDs, beyond tumor necrosis factor inhibitors
…, V Koulouri, A Iliopoulos… - Therapeutic …, 2020 - journals.sagepub.com
Patients with autoimmune rheumatic diseases (ARD) have an increased risk for tuberculosis
(TB). The use of tumor necrosis factor inhibitors (TNFi) and glucocorticoids in these patients …
(TB). The use of tumor necrosis factor inhibitors (TNFi) and glucocorticoids in these patients …
Higher depression rates and similar cardiovascular comorbidity in psoriatic arthritis compared with rheumatoid arthritis and diabetes mellitus
…, G Konstantonis, A Iliopoulos… - Therapeutic …, 2020 - journals.sagepub.com
Background: We explore the spectrum of comorbidities in psoriatic arthritis (PsA) patients in
comparison with other high comorbidity-burden diseases like rheumatoid arthritis (RA) and …
comparison with other high comorbidity-burden diseases like rheumatoid arthritis (RA) and …
Depression and anxiety in a real-world psoriatic arthritis longitudinal study: should we focus more on patients' perception?
…, K Kouna, A Karamanakos, A Iliopoulos… - Clinical and …, 2023 - eprints.gla.ac.uk
Objectives: Longitudinal studies using validated tools to evaluate depression and anxiety in
psoriatic arthritis (PsA) are lacking. We aimed to estimate their course in PsA and to examine …
psoriatic arthritis (PsA) are lacking. We aimed to estimate their course in PsA and to examine …
Serum levels of Dkk-1, sclerostin and VEGF in patients with ankylosing spondylitis and their association with smoking, and clinical, inflammatory and radiographic …
GT Sakellariou, A Iliopoulos, M Konsta, E Kenanidis… - Joint Bone Spine, 2017 - Elsevier
Objective To evaluate serum Dickkopf-1 (Dkk-1), sclerostin and vascular endothelial growth
factor (VEGF) levels in patients with ankylosing spondylitis (AS) compared to healthy …
factor (VEGF) levels in patients with ankylosing spondylitis (AS) compared to healthy …
Cranial giant cell arteritis mimickers: a masquerade to unveil
…, A Grivas, M Pappa, K Kouna, A Iliopoulos… - Autoimmunity …, 2022 - Elsevier
Giant cell arteritis (GCA) is a large-vessel vasculitis that affects cranial and extra-cranial
arteries. Extra-cranial GCA presents mainly with non-specific symptoms and the differential …
arteries. Extra-cranial GCA presents mainly with non-specific symptoms and the differential …
[HTML][HTML] Rebound-associated vertebral fractures may occur in sequential time points following denosumab discontinuation: need for prompt treatment re-initiation
…, G Evangelatos, P Makras, A Iliopoulos - Bone Reports, 2020 - Elsevier
Denosumab discontinuation has been associated with increased risk of rebound-associated
multiple vertebral fractures. We report the cases of three patients, two females and one male…
multiple vertebral fractures. We report the cases of three patients, two females and one male…
Hypogammaglobulinemia after rituximab for rheumatoid arthritis is not rare and is related with good response: 13 years real-life experience
…, M Moschopoulou, D Vassilopoulos, A Iliopoulos - …, 2021 - academic.oup.com
Objectives Rituximab (RTX) use in the treatment of RA can be complicated by decrease in
IgG, IgM or IgA levels (hypogammaglobulinemia-HGG). The aim of this study was to define the …
IgG, IgM or IgA levels (hypogammaglobulinemia-HGG). The aim of this study was to define the …